Biostax Corp (BTAX)

[locicat1]

The only patent assigned to Cytocom, Inc. is the Jill Smith, M.D. and her group patent for the treatment of Crohn's Disease. As I stated in my posting on 11/07/18 the newly issued patent to Immune Therapeutics, Inc. is very broad and general in its coverage AND is potentially highly significant. I am still puzzled that all the shareholders out there do not seem to be responding to the implications-this is a new U.S. Patent covering the USE of LDN over a broad swath of therapeutic potential and IF the claims hold IMUN has the absolute rights to the commerce of these broad therapeutic potentials noted in the patent for at least 17 years.

NOW the question posed earlier--Where is the 8-K for this issued patent??